Splenectomy may facilitate systemic therapy for advanced hepatocellular carcinoma with hypersplenism
Hepatobiliary Surgery and Nutrition · 2023-02 · 12 (1) · 137-139
DOI: 10.21037/hbsn-22-545 ↗Kurz gefasst
Editorial in der Zeitschrift Hepatobiliary Surgery and Nutrition, 2023-02. Verfasst von Er-Lei Zhang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Hepatic Surgery Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Die Arbeit wurde bisher 7-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Hepatic Surgery Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Zitieren
APA
Zhang, E. L., Zhang, Z. Y., & Huang, Z. Y. (2023). Splenectomy may facilitate systemic therapy for advanced hepatocellular carcinoma with hypersplenism. Hepatobiliary Surgery and Nutrition, 12(1), 137-139. https://doi.org/10.21037/hbsn-22-545
Vancouver
Zhang EL, Zhang ZY, Huang ZY. Splenectomy may facilitate systemic therapy for advanced hepatocellular carcinoma with hypersplenism. Hepatobiliary Surgery and Nutrition. 2023;12(1):137-139. doi:10.21037/hbsn-22-545
BibTeX
@article{Zhang2023,
author = {Zhang, Er-Lei and Zhang, Zun-Yi and Huang, Zhi-Yong},
title = {Splenectomy may facilitate systemic therapy for advanced hepatocellular carcinoma with hypersplenism},
journal = {Hepatobiliary Surgery and Nutrition},
year = {2023},
volume = {12},
number = {1},
pages = {137--139},
doi = {10.21037/hbsn-22-545}
}
EUVIMED